These emerging treatments, Semaglutide , represent a remarkable advancement in managing obesity and possibly associated disorders. They all are grouped as GLP-1 receptor stimulators, signifying they to emulate the natural GLP-1 substance , boosting metabolic secretion and lowering appetite . Desp